Guangzheng Eye Hospital Group Co.,Ltd. (SHE:002524)
China · Delayed Price · Currency is CNY 4.710
+0.010 (0.21%)
At close: Feb 6, 2026
SHE:002524 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 824.59 | 859.88 | 1,041 | 743.26 | 1,027 | 903.53 |
Other Revenue | 32.96 | 32.96 | 33.85 | 24.19 | 17.65 | 17.52 |
| 857.56 | 892.84 | 1,075 | 767.44 | 1,044 | 921.05 | |
Revenue Growth (YoY) | -9.43% | -16.94% | 40.06% | -26.52% | 13.40% | -28.32% |
Cost of Revenue | 547.63 | 566.61 | 700.04 | 576.9 | 712.08 | 607.18 |
Gross Profit | 309.92 | 326.24 | 374.86 | 190.55 | 332.4 | 313.87 |
Selling, General & Admin | 291.72 | 324.03 | 325.9 | 276.67 | 342.85 | 272.5 |
Research & Development | 3.58 | 3.58 | 4.97 | 0.86 | 3.96 | 0.54 |
Other Operating Expenses | 4.35 | 3.99 | 4.51 | 4.51 | -14.7 | 6.3 |
Operating Expenses | 296.82 | 332.39 | 338.03 | 283.81 | 326.41 | 290.18 |
Operating Income | 13.1 | -6.15 | 36.83 | -93.26 | 5.99 | 23.69 |
Interest Expense | -36 | -38.38 | -38.75 | -36.34 | -37.71 | -26.42 |
Interest & Investment Income | 16.11 | 15.4 | 1.48 | 0.89 | 81.35 | 62.15 |
Other Non Operating Income (Expenses) | 2.24 | -2.46 | -1.67 | -0.95 | -6.4 | -2.45 |
EBT Excluding Unusual Items | -4.55 | -31.59 | -2.12 | -129.67 | 43.22 | 56.97 |
Impairment of Goodwill | -134.63 | -134.63 | -1.26 | -138.63 | -5.74 | -15.25 |
Gain (Loss) on Sale of Investments | - | - | - | -20.51 | - | - |
Gain (Loss) on Sale of Assets | 0.68 | 5.02 | 1.7 | 1.04 | 7.2 | 2.6 |
Asset Writedown | 0.32 | -0.04 | -0.08 | -0.09 | -0.04 | -0.77 |
Other Unusual Items | -2.41 | 0.15 | 9.68 | 212.28 | 0.3 | 2.41 |
Pretax Income | -140.6 | -161.09 | 7.91 | -75.58 | 44.94 | 45.95 |
Income Tax Expense | 13.72 | 13.89 | -1.83 | 2.22 | 8.49 | 13.86 |
Earnings From Continuing Operations | -154.31 | -174.98 | 9.75 | -77.8 | 36.44 | 32.1 |
Minority Interest in Earnings | 0.64 | 0.32 | -0.49 | -0.42 | 0.48 | 10.5 |
Net Income | -153.67 | -174.65 | 9.26 | -78.22 | 36.93 | 42.6 |
Net Income to Common | -153.67 | -174.65 | 9.26 | -78.22 | 36.93 | 42.6 |
Net Income Growth | - | - | - | - | -13.31% | -41.38% |
Shares Outstanding (Basic) | - | 514 | 463 | 521 | 501 | 504 |
Shares Outstanding (Diluted) | - | 514 | 463 | 521 | 517 | 516 |
Shares Change (YoY) | - | 11.01% | -11.26% | 0.81% | 0.17% | 1.55% |
EPS (Basic) | - | -0.34 | 0.02 | -0.15 | 0.07 | 0.08 |
EPS (Diluted) | - | -0.34 | 0.02 | -0.15 | 0.07 | 0.08 |
EPS Growth | - | - | - | - | -12.50% | -42.86% |
Free Cash Flow | 47.09 | 43.32 | 15.48 | 83.61 | 92.91 | 92.9 |
Free Cash Flow Per Share | - | 0.08 | 0.03 | 0.16 | 0.18 | 0.18 |
Gross Margin | 36.14% | 36.54% | 34.87% | 24.83% | 31.82% | 34.08% |
Operating Margin | 1.53% | -0.69% | 3.43% | -12.15% | 0.57% | 2.57% |
Profit Margin | -17.92% | -19.56% | 0.86% | -10.19% | 3.54% | 4.63% |
Free Cash Flow Margin | 5.49% | 4.85% | 1.44% | 10.90% | 8.89% | 10.09% |
EBITDA | 42.24 | 26.05 | 73.13 | -52.89 | 55.01 | 86.33 |
EBITDA Margin | 4.93% | 2.92% | 6.80% | -6.89% | 5.27% | 9.37% |
D&A For EBITDA | 29.14 | 32.21 | 36.3 | 40.38 | 49.02 | 62.64 |
EBIT | 13.1 | -6.15 | 36.83 | -93.26 | 5.99 | 23.69 |
EBIT Margin | 1.53% | -0.69% | 3.43% | -12.15% | 0.57% | 2.57% |
Effective Tax Rate | - | - | - | - | 18.90% | 30.15% |
Revenue as Reported | 857.56 | 892.84 | 1,075 | 767.44 | 1,044 | 921.05 |
Advertising Expenses | - | 92.79 | 91.01 | 68.82 | 108.57 | 78.46 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.